Dakota Venture Group (DVG) is a venture capital investment fund operated by students at the University of North Dakota. Established in 2006, it holds the distinction of being the first entirely student-run venture capital fund in the United States. DVG offers students a unique opportunity to engage in all aspects of the investment process, including conducting due diligence, making final investment decisions, and negotiating deal terms. The organization focuses on investing in high-growth companies across the United States, providing a valuable experiential learning platform in the fields of venture capital and angel investing.
Managing Director of Information Technology and Operations and Board Member
Butler, Paul
Managing Associate
Dylan Diede
Managing Director, Finance
Tyler Eiken
Board Member and Managing Director, Finance
Austin Emineth
Managing Director of Information Technology and Operations, Managing Associate and Board Member
Dylan Foley
Managing Director, Finance
Dara Morehouse
Managing Director of Information Technology and Operations and Executive, Alumni
Jacob Oleksik
Managing Director of Finance, Managing Associate and Board Member
Amanda Perez
Managing Director of IT and Operations
4 past transactions
Voxello
Series A in 2016
Voxello, Inc. specializes in developing and marketing communication devices aimed at improving the interaction capabilities of disabled hospitalized patients. The company's flagship product, known as noddle, is a communication device that integrates with ventilators and utilizes Bluetooth technology to connect with other devices. Voxello's innovative approach includes patented technology that detects subtle gestures, allowing patients to access nurse call systems and utilize a proprietary chat application. Founded in 2013 and headquartered in Coralville, Iowa, Voxello aims to create universally adaptable assistive technology devices, including a range of input devices such as microphones and switches, to enhance communication for patients in hospitals and long-term care settings.
Youbetme
Series A in 2014
Youbetme is a consumer technology platform that facilitates peer-to-peer social betting, allowing users to place bets with friends on a variety of events. The service aims to enhance the social experience of betting, making it accessible to sports enthusiasts, college students, and young professionals looking for a fun way to engage in friendly wagers. The platform is designed to be user-friendly, featuring tools for tracking bets through a text message system, enabling users to bet from any location. Youbetme has received $1,225,000 in seed funding to support its marketing launch and ongoing development. The company was co-founded by Jason Neubauer and Justin Jarman, with a team that includes experienced professionals from the tech and gaming industries. The native iOS app is available for download, positioning Youbetme as a modern solution for social betting among friends.
Buzz360
Venture Round in 2014
Buzz360 LLC is a Minneapolis-based company that specializes in creating a software-as-a-service marketing automation platform designed for small businesses and various organizations, including media firms and franchisors. Founded in 2011, Buzz360 offers a suite of features that facilitate automated social media posts, customer reviews, and search engine optimization. Its platform enables small businesses to engage customers through automated email marketing, generate social referrals, and maintain an online presence with user-friendly websites. Additionally, Buzz360's white-label community platform allows partners, such as advertising agencies and non-profit organizations, to create tailored marketing tools for specific sectors. This architecture supports multi-tenant capabilities and is geared towards helping small businesses attract new customers and foster repeat business, ultimately streamlining marketing efforts and enhancing profitability.
EmboMedics
Series A in 2013
EmboMedics, Inc. is a medical technology company focused on developing and commercializing resorbable and drug-loaded embolization materials for various medical applications. Founded in 2012 and based in Minnesota, the company offers products for conditions such as uterine fibroid embolization, trauma, benign prostatic hyperplasia, and trans-arterial chemoembolization. Their innovative technology includes resorbable embolic microspheres, which are designed to selectively block arteries by introducing foreign bodies that impede blood flow while allowing minimal invasiveness. This approach enables healthcare professionals to effectively target and treat tumors by combining embolization with chemotherapy, enhancing therapeutic outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.